Expertise in
4
conditions

Kun-ho H. Yoon

St. Vincent's Hospital, 
Suwon, KR 
Expertise in
4
conditions
St. Vincent's Hospital, 
Suwon, KR 

Overview

Kun-ho Yoon practices practicing medicine in Suwon, Republic of Korea.

Yoon is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Low Blood Sugar, Abdominal Obesity Metabolic Syndrome, and Islet Cell Transplantation.

They are actively involved in clinical research, co-authoring 161 peer reviewed articles and participating in 5 clinical trials.

Locations

St. Vincent's Hospital, Suwon, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes
Enrollment Status: Completed
Publish Date: January 19, 2022
Intervention Type: Drug
Study Phase: Phase 3
An Extension Study of Protocol ALO-IIT(PEAK Study) to Examine the Long-term Efficacy and Safety of Metformin + Alogliptin + Pioglitazone Triple Combination Therapy in the Korean Type 2 Diabetes Patients
An Extension Study of Protocol ALO-IIT(PEAK Study) to Examine the Long-term Efficacy and Safety of Metformin + Alogliptin + Pioglitazone Triple Combination Therapy in the Korean Type 2 Diabetes Patients
Enrollment Status: Terminated
Publish Date: June 05, 2019
Intervention Type: Drug
Study Phase: Phase 4
Multicenter, Randomized, Double Blind, Three-arm Parallel Group Study to Evaluate Efficacy and Safety of Alogliptin and Pioglitazone Combination Therapy on Glucose Control in Type 2 Diabetes Subjects Who Have Inadequate Control With Metformin Monotherapy in Korea
Multicenter, Randomized, Double Blind, Three-arm Parallel Group Study to Evaluate Efficacy and Safety of Alogliptin and Pioglitazone Combination Therapy on Glucose Control in Type 2 Diabetes Subjects Who Have Inadequate Control With Metformin Monotherapy in Korea
Enrollment Status: Completed
Publish Date: February 08, 2019
Intervention Type: Drug
Study Phase: Phase 4
Effect of Dapagliflozin on Glycemic Variability as an add-on Therapy in Subjects With Type 2 Diabetes Mellitus With in Inadequate Glycemic Control in Insulin: a Multicenter, Placebo-controlled, Double-blind, Randomized Study
Effect of Dapagliflozin on Glycemic Variability as an add-on Therapy in Subjects With Type 2 Diabetes Mellitus With in Inadequate Glycemic Control in Insulin: a Multicenter, Placebo-controlled, Double-blind, Randomized Study
Enrollment Status: Completed
Publish Date: July 13, 2017
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials

161 Total Publications

β-cell recovery revisited: Is prediabetes remission driven by insulin sensitivity or β-cell function?
β-cell recovery revisited: Is prediabetes remission driven by insulin sensitivity or β-cell function?
Journal: Journal of diabetes investigation
Published: March 07, 2026

Frequently Asked Questions about Kun-ho H. Yoon

Is Kun-ho H. Yoon a top-rated expert for Maturity Onset Diabetes of the Young?

MediFind is an objective health platform that identifies experts based on real-world data. Kun-ho H. Yoon is classified as an Distinguished expert for Maturity Onset Diabetes of the Young, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kun-ho H. Yoon participate in research or clinical trials?

Yes. Kun-ho H. Yoon has published 161 articles and abstracts on conditions like Maturity Onset Diabetes of the Young. You can view a list of Kun-ho H. Yoon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yoon's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile